Literature DB >> 29712537

Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progression.

Yan Mei1, Jun-Ping Yang1, Yan-Hong Lang1, Li-Xia Peng1, Ming-Ming Yang2, Qing Liu2, Dong-Fang Meng1, Li-Sheng Zheng1, Yuan-Yuan Qiang1, Liang Xu1, Chang-Zhi Li1, Wen-Wen Wei1, Ting Niu2, Xing-Si Peng1, Qin Yang1, Fen Lin1, Hao Hu3, Hong-Fa Xu4, Bi-Jun Huang1, Li-Jing Wang2, Chao-Nan Qian1,5.   

Abstract

It is believed that the alteration of tissue microenvironment would affect cancer initiation and progression. However, little is known in terms of the underlying molecular mechanisms that would affect the initiation and progression of breast cancer. In the present study, we use two murine mammary tumor models with different speeds of tumor initiation and progression for whole genome expression profiling to reveal the involved genes and signaling pathways. The pathways regulating PI3K-Akt signaling and Ras signaling were activated in Fvb mice and promoted tumor progression. Contrastingly, the pathways regulating apoptosis and cellular senescence were activated in Fvb.B6 mice and suppressed tumor progression. We identified distinct patterns of oncogenic pathways activation at different stages of breast cancer, and uncovered five oncogenic pathways that were activated in both human and mouse breast cancers. The genes and pathways discovered in our study would be useful information for other researchers and drug development.

Entities:  

Keywords:  Apoptosis; Breast cancer; Cancer progression; PI3K-Akt signaling; RNA-sequencing; Ras signaling

Mesh:

Year:  2018        PMID: 29712537      PMCID: PMC6103659          DOI: 10.1080/15384101.2018.1442629

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  65 in total

Review 1.  Signaling properties of hyaluronan receptors.

Authors:  Eva A Turley; Paul W Noble; Lilly Y W Bourguignon
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

Review 2.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 3.  Fibronectin at a glance.

Authors:  Roumen Pankov; Kenneth M Yamada
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 4.  PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.

Authors:  Angel Guerrero-Zotano; Ingrid A Mayer; Carlos L Arteaga
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

5.  Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.

Authors:  M A Webster; J N Hutchinson; M J Rauh; S K Muthuswamy; M Anton; C G Tortorice; R D Cardiff; F L Graham; J A Hassell; W J Muller
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

8.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

9.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.

Authors:  Joseph A Ludwig; Salah-Eddine Lamhamedi-Cherradi; Ho-Young Lee; Aung Naing; Robert Benjamin
Journal:  Cancers (Basel)       Date:  2011-07-26       Impact factor: 6.639

View more
  3 in total

1.  Genome-wide DNA methylome and whole-transcriptome landscapes of spontaneous intraductal papilloma in tree shrews.

Authors:  Chengxiu Liu; Yuanyuan Han; Pinfen Tong; Dexuan Kuang; Na Li; Caixia Lu; Xiaomei Sun; Wenguang Wang; Jiejie Dai
Journal:  Ann Transl Med       Date:  2021-04

2.  A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer.

Authors:  Yi Li; Kexin Wang; Yupeng Chen; Jieqi Cai; Xuemei Qin; Aiping Lu; Daogang Guan; Genggeng Qin; Weiguo Chen
Journal:  Front Pharmacol       Date:  2021-11-16       Impact factor: 5.810

Review 3.  The Viral Origin of Human Breast Cancer: From the Mouse Mammary Tumor Virus (MMTV) to the Human Betaretrovirus (HBRV).

Authors:  Generoso Bevilacqua
Journal:  Viruses       Date:  2022-08-01       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.